Literature DB >> 16823808

BACE1 interacts with lipid raft proteins.

Chinatsu Hattori1, Masashi Asai, Hayato Onishi, Noboru Sasagawa, Yasuhiro Hashimoto, Takaomi C Saido, Kei Maruyama, Shigehiko Mizutani, Shoichi Ishiura.   

Abstract

A neuropathological hallmark of Alzheimer's disease is the presence of amyloid plaques in the brain. Amyloid-beta peptide (Abeta) is the major constituent of the plaques and is generated by proteolytic cleavages of amyloid precursor protein (APP) by beta- and gamma-secretases. Growing evidence shows that lipid rafts are critically involved in regulating the Abeta generation. In support of this, APP, Abeta, and presenilins have been found in lipid rafts. Although cholesterol plays a crucial role in maintaining lipid rafts, functions of other components in the generation of Abeta are unknown. Caveolins (CAVs) and flotillins (FLOTs) are principal proteins related to lipid rafts and have been suggested to be involved in APP processing. Here, we report that FLOT-1 binds to BACE1 (beta-site APP cleaving enzyme 1) and that overexpression of CAV-1 or FLOT-1 results in recruiting BACE1 into lipid rafts and influence on beta-secretase activity in cultured cells. Our results show that both CAV-1 and FLOT-1 may modulate beta-secretase activity by interacting with BACE1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16823808     DOI: 10.1002/jnr.20981

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  32 in total

1.  Identification of novel γ-secretase-associated proteins in detergent-resistant membranes from brain.

Authors:  Ji-Yeun Hur; Yasuhiro Teranishi; Takahiro Kihara; Natsuko Goto Yamamoto; Mitsuhiro Inoue; Waltteri Hosia; Masakazu Hashimoto; Bengt Winblad; Susanne Frykman; Lars O Tjernberg
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

Review 2.  Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.

Authors:  Toshio Ariga; Michael P McDonald; Robert K Yu
Journal:  J Lipid Res       Date:  2008-03-11       Impact factor: 5.922

3.  Soluble amyloid beta-oligomers affect dielectric membrane properties by bilayer insertion and domain formation: implications for cell toxicity.

Authors:  Gintaras Valincius; Frank Heinrich; Rima Budvytyte; David J Vanderah; Duncan J McGillivray; Yuri Sokolov; James E Hall; Mathias Lösche
Journal:  Biophys J       Date:  2008-05-30       Impact factor: 4.033

Review 4.  Linking lipids to Alzheimer's disease: cholesterol and beyond.

Authors:  Gilbert Di Paolo; Tae-Wan Kim
Journal:  Nat Rev Neurosci       Date:  2011-03-30       Impact factor: 34.870

5.  Palmitoylation of amyloid precursor protein regulates amyloidogenic processing in lipid rafts.

Authors:  Raja Bhattacharyya; Cory Barren; Dora M Kovacs
Journal:  J Neurosci       Date:  2013-07-03       Impact factor: 6.167

6.  COPS5 protein overexpression increases amyloid plaque burden, decreases spinophilin-immunoreactive puncta, and exacerbates learning and memory deficits in the mouse brain.

Authors:  Ruizhi Wang; Hongjie Wang; Ivan Carrera; Shaohua Xu; Madepalli K Lakshmana
Journal:  J Biol Chem       Date:  2015-02-20       Impact factor: 5.157

Review 7.  Copper in the brain and Alzheimer's disease.

Authors:  Ya Hui Hung; Ashley I Bush; Robert Alan Cherny
Journal:  J Biol Inorg Chem       Date:  2009-10-28       Impact factor: 3.358

8.  Why are lipid rafts not observed in vivo?

Authors:  Arun Yethiraj; James C Weisshaar
Journal:  Biophys J       Date:  2007-07-27       Impact factor: 4.033

Review 9.  Mechanisms of disease: new therapeutic strategies for Alzheimer's disease--targeting APP processing in lipid rafts.

Authors:  Haipeng Cheng; Kulandaivelu S Vetrivel; Ping Gong; Xavier Meckler; Angèle Parent; Gopal Thinakaran
Journal:  Nat Clin Pract Neurol       Date:  2007-07

Review 10.  Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer's disease.

Authors:  Isidre Ferrer
Journal:  J Bioenerg Biomembr       Date:  2009-10       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.